Post# 3526 has a link to a BMY Onc Presentation 3/28. The presentation has a slide showing a bispecific adnectin targeting IGFR and EGFR. I only looked at the slides; I'm not sure what was said during the presentation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.